CBT · Cabot Corp
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $3.63B | $3.71B | $3.99B | $3.93B | $4.32B | $3.41B | $2.61B | $3.34B | $3.24B | $2.72B | $2.41B | $2.87B | $3.65B | $3.46B | $3.29B | $3.1B | $2.72B | $2.11B | $3.19B | |
| — | $2.81B | $2.77B | $3.03B | $3.09B | $3.44B | $2.61B | $2.11B | $2.65B | $2.47B | $2.06B | $1.84B | $2.29B | $2.93B | $2.82B | $2.65B | $2.54B | $2.21B | $1.89B | $2.71B | |
| — | $825M | $940M | $960M | $839M | $885M | $799M | $500M | $685M | $772M | $657M | $575M | $585M | $721M | $633M | $644M | $558M | $510M | $217M | $484M | |
| — | — | 25.32% | 24.04% | 21.34% | 20.48% | 23.44% | 19.13% | 20.53% | 23.81% | 24.18% | 23.85% | 20.38% | 19.77% | 18.32% | 19.57% | 17.99% | 18.78% | 10.29% | 15.17% | |
| — | $55M | $59M | $63M | $57M | $55M | $56M | $57M | $60M | $66M | $57M | $53M | $58M | $60M | $68M | $72M | $66M | $65M | $66M | $74M | |
| — | $277M | $260M | $283M | $253M | $258M | $289M | $292M | $290M | $308M | $262M | $275M | $282M | $326M | $297M | $281M | $249M | $241M | $205M | $246M | |
| — | $180M | $154M | $151M | $144M | $146M | $160M | $158M | $148M | $149M | $155M | $161M | $183M | $201M | $190M | $154M | $142M | $137M | $164M | $163M | |
| — | — | $11M | $13M | $4M | $3M | $11M | $19M | $16M | -$30M | $25M | $29M | $21M | $29M | $35M | $15M | $18M | $46M | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $2M | — | — | |
| — | $493M | $621M | $614M | $526M | $389M | $454M | $21M | $306M | $144M | $338M | $247M | -$317M | $335M | $268M | $291M | $243M | $204M | -$54M | $164M | |
| — | — | 16.73% | 15.37% | 13.38% | 9% | 13.32% | 0.8% | 9.17% | 4.44% | 12.44% | 10.24% | -11.04% | 9.19% | 7.75% | 8.84% | 7.83% | 7.51% | -2.56% | 5.14% | |
| — | $673M | $775M | $765M | $670M | $535M | $614M | $179M | $454M | $293M | $493M | $408M | -$134M | $536M | $458M | $445M | $385M | $341M | $110M | $327M | |
| — | $74M | $76M | $81M | $90M | $56M | $49M | $53M | $59M | $54M | $53M | $54M | $53M | $55M | $62M | $46M | $39M | $40M | $30M | $38M | |
| — | $5M | — | — | — | — | — | — | — | — | — | — | — | — | — | $4M | $2M | $2M | $3M | $4M | |
| — | — | -$7M | -$36M | -$16M | -$9M | -$7M | -$9M | -$1M | $17M | $5M | -$7M | -$11M | $25M | -$1M | -$3M | -$3M | -$2M | -$18M | -$18M | |
| — | $7M | $7M | $6M | $5M | $10M | $3M | $3M | $1M | $2M | $7M | $3M | $4M | — | $11M | $11M | $8M | $7M | $5M | $8M | |
| — | $411M | $565M | $529M | $451M | $335M | $406M | -$33M | $255M | $117M | $299M | $191M | -$377M | $308M | $210M | $245M | $203M | $166M | -$99M | $112M | |
| — | $190M | $196M | $111M | -$28M | $102M | $123M | $191M | $70M | $193M | $33M | $33M | -$45M | $92M | $60M | $55M | $6M | $30M | -$21M | $14M | |
| — | $168M | $331M | $380M | $445M | $209M | $250M | -$238M | $157M | -$113M | $248M | $147M | -$334M | $199M | $153M | $388M | $236M | $154M | -$77M | $86M | |
| — | — | 8.91% | 9.51% | 11.32% | 4.84% | 7.33% | -9.1% | 4.7% | -3.49% | 9.13% | 6.1% | -11.63% | 5.46% | 4.43% | 11.79% | 7.61% | 5.67% | -3.65% | 2.7% | |
| — | $38M | $45M | $44M | $39M | $34M | $36M | $17M | $29M | $39M | $25M | $15M | $8M | $19M | $7M | $18M | $22M | $15M | $2M | $20M | |
| — | $187M | $326M | $374M | $437M | $206M | $247M | -$238M | $155M | -$114M | $246M | $146M | -$334M | $197M | $152M | $385M | $233M | $151M | -$79M | — | |
| — | $278M | $356M | $382M | $522M | $59M | $312M | -$195M | $83M | -$171M | $314M | $121M | -$569M | $32M | $164M | $374M | $254M | — | — | — | |
| USD/shares | — | $3.57 | $6.07 | $6.79 | $7.79 | $3.65 | $4.35 | -$4.21 | $2.64 | -$1.85 | $3.94 | $2.34 | -$5.27 | $3.06 | $2.38 | $6.07 | $3.62 | $2.37 | -$1.25 | $1.32 |
| USD/shares | $6.15 – $6.45* | $3.56 | $6.02G | $6.72G | $7.73G | $3.62G | $4.34 | -$4.21 | $2.63 | -$1.85 | $3.91 | $2.32 | -$5.27 | $3.03 | $2.36 | $5.99 | $3.57 | $2.35 | -$1.25 | $1.32 |
| shares | — | — | 53.7M | 55.1M | 56.1M | 56.5M | 56.7M | 56.6M | 58.7M | 61.7M | 62.3M | 62.4M | 63.4M | 64.4M | 63.8M | 63.4M | 64.6M | 63.8M | 62.8M | 63M |
| shares | — | — | 54.2M | 55.7M | 56.5M | 56.9M | 56.8M | 56.6M | 58.8M | 61.7M | 62.7M | 62.9M | 63.4M | 65.1M | 64.5M | 64.2M | 65.4M | 64.3M | 62.8M | 63M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $1.22B in buybacks, $1.22B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 33 similar-size Specialty Chemicals companies (of 63 listed).
EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Reinforcement Materials | $2,341,000,000 | $2,610,000,000 | $2,563,000,000 | $2,673,000,000 | $1,838,000,000 | $1,256,000,000 | $1,815,000,000 | $1,774,000,000 |
| Performance Chemicals | $1,250,000,000 | $1,250,000,000 | $1,225,000,000 | $1,388,000,000 | $1,156,000,000 | $933,000,000 | $995,000,000 | $1,028,000,000 |
| Purification Solutions | — | — | — | $97,000,000 | $257,000,000 | $253,000,000 | $278,000,000 | $279,000,000 |
| Specialty Fluids | — | — | — | — | — | — | $56,000,000 | $45,000,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| OtherForeignCountries | $2,112,000,000 | $2,278,000,000 | $2,221,000,000 | $2,350,000,000 | $1,883,000,000 | $1,435,000,000 | $1,897,000,000 | $1,814,000,000 |
| Asia Pacific | $1,401,000,000 | $1,521,000,000 | $1,486,000,000 | $1,630,000,000 | $1,300,000,000 | $931,000,000 | $1,158,000,000 | — |
| Americas | $1,317,000,000 | $1,434,000,000 | $1,425,000,000 | $1,534,000,000 | $1,129,000,000 | $868,000,000 | $1,114,000,000 | — |
| China | $931,000,000 | $983,000,000 | $972,000,000 | $1,129,000,000 | $858,000,000 | $598,000,000 | $738,000,000 | $752,000,000 |
| EMEA | $873,000,000 | $905,000,000 | $877,000,000 | $994,000,000 | $822,000,000 | $643,000,000 | $872,000,000 | — |
| United States | $670,000,000 | $733,000,000 | $738,000,000 | $842,000,000 | $668,000,000 | $581,000,000 | $702,000,000 | $676,000,000 |
By Product & Service (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Performance Additives | $1,013,000,000 | $796,000,000 | $645,000,000 | $694,000,000 | $707,000,000 |
| Formulated Solutions | $359,000,000 | $352,000,000 | $288,000,000 | $301,000,000 | $321,000,000 |